January 30, 2019
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2,…
Read More
January 30, 2019
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2,…
Read More
January 30, 2019
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2,…
Read More
January 30, 2019
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2,…
Read More
January 30, 2019
Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4…
Read More
January 30, 2019
Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4…
Read More
January 30, 2019
Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio’s DTPa-HBV-IPV/Hib Vaccine
Read More
January 30, 2019
Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio’s DTPa-HBV-IPV/Hib Vaccine
Read More
January 30, 2019
Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals’ DTPa-HBV-IP...
Read More
January 30, 2019
Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals’ DTPa-HBV-IP...
Read More
January 30, 2019
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals&...
Read More
January 30, 2019
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals&...
Read More
Load More